Clovis Oncology Inc EV/Sales
Qual é o EV/Sales de Clovis Oncology Inc?
O EV/Sales de Clovis Oncology Inc é 4.91
Qual é a definição de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales de empresas na Setor Health Care em NASDAQ em comparação com Clovis Oncology Inc
Empresas com ev/sales semelhantes a Clovis Oncology Inc
- Elecon Engineering tem EV/Sales de 4.90
- Hamborner REIT AG tem EV/Sales de 4.90
- Dun & Bradstreet tem EV/Sales de 4.90
- Hut 8 Mining tem EV/Sales de 4.90
- Wall tem EV/Sales de 4.91
- Trainline Plc tem EV/Sales de 4.91
- Clovis Oncology Inc tem EV/Sales de 4.91
- Omkar Speciality Chemicals tem EV/Sales de 4.91
- Diversified Gas & Oil PLC tem EV/Sales de 4.91
- Tata Consultancy Services tem EV/Sales de 4.91
- Victory Securities () tem EV/Sales de 4.91
- Steris Plc tem EV/Sales de 4.91
- Diageo Plc tem EV/Sales de 4.92